Identification | Back Directory | [Name]
SECOISOLARICIRESINOL | [CAS]
29388-59-8 | [Synonyms]
SCUTELLARIN(P) Secoisolariciresil Secoisolariciresino SECOISOLARICIRESINOL (–)-Secoisolariciresinol (-)-secoisolariciresinol (-)-SECO-ISOLARICIRESINOL SECOISOLARICIRESINOL 95+% (+/-)-SECOISOLARICIRESINOL SECO-ISOLARICIRESINOL (SECO) Secoisolariciresinol >=95.0% (HPLC) 4,4',9,9'-TETRHYDROXY-3,3'-DIMETHOXYLIGNAN (2R,3R)-2,3-BIS(4-HYDROXY-3-METHOXYBENZYL)-1,4-BUTANEDIOL (2R,3R)-2,3-Bis(3-methoxy-4-hydroxybenzyl)butane-1,4-diol (2R,3R)-2,3-Bis(4-hydroxy-3-methoxybenzyl)butane-1,4-diol [R-(R*,R*)]-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane... (2R,3R)-1,4-Bis(4-hydroxy-3-methoxyphenyl)butane-2,3-bismethanol (2R,3R)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol 1,4-Butanediol, 2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]-, (2R,3R)- [2R,3R,(-)]-2,3-Bis[(4-hydroxy-3-methoxyphenyl)methyl]-1,4-butanediol [R-(R*,R*)]-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol 4,4'-[(2R,3R)-2,3-Bis(hydroxymethyl)-1,4-butanediyl]bis(2-methoxyphenol) Secoisolariciresinol,(2R*,3R*)-2,3-Bis(4-hydroxy-3-methoxybenzyl)-1,4-butanediol | [EINECS(EC#)]
249-599-2 | [Molecular Formula]
C20H26O6 | [MDL Number]
MFCD01075136 | [MOL File]
29388-59-8.mol | [Molecular Weight]
362.42 |
Chemical Properties | Back Directory | [Melting point ]
113 °C | [Boiling point ]
609.1±55.0 °C(Predicted) | [density ]
1.251±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
DMSO: 10 mM | [form ]
A crystalline solid | [pka]
9.81±0.20(Predicted) | [color ]
White to off-white | [BRN ]
6611290 |
Hazard Information | Back Directory | [Uses]
Secoisolariciresinol is a Mongolian folk medicine with anti-myocardial ischemia effects. Possesses anti-oxidant and anti-microbial activity. | [Definition]
ChEBI: (-)-secoisolariciresinol is an enantiomer of secoisolariciresinol having (-)-(2R,3R)-configuration. It has a role as an antidepressant, a plant metabolite and a phytoestrogen. It is an enantiomer of a (+)-secoisolariciresinol. |
|
|